The role of PI3K/mTOR inhibition in combination with sorafenib in hepatocellular carcinoma treatment

Roberto Gedaly, Angulo Paul, Changguo Chen, Kate Townsend Creasy, Brett T. Spear, Jonathan Hundley, Michael F. Daily, Malay Shah, B. Mark Evers

Research output: Contribution to journalArticlepeer-review

39 Scopus citations

Fingerprint

Dive into the research topics of 'The role of PI3K/mTOR inhibition in combination with sorafenib in hepatocellular carcinoma treatment'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science